$GTCH "We are excited to start new research for our qTerm device" stated Danny Rittman, GBT's CTO. "This research is about the analysis of Kirlian electrophotography data in order to detect an onset of possible illnesses. Kirlian imaging can produce a bio-energy of human's organs and can perform as a diagnostic tool. Using Kirlian imaging, we believe it is possible to produce a measure of human energy levels and examine changes in the energy distribution throughout the organ(s). We are attempting to determine if we can implement Kirlian imaging for qTerm by means of producing a human's finger aura (i.e. its biofield). Along with qTerm vitals measurement, the goal is to potentially provide a Kirilian image. In turn, using our Machine learning technology, we are seeking to develop an analysis of the biofield and, in turn, provide a diagnostic and potential medical issues classification. We believe this type of system, if fully developed and commercialized, could be very efficient as additional diagnostic system. We commenced our research and we encourage public participation in this research and we will share our findings on our website qterm.me" continued Dr. Rittman.
$GTCH "We are excited to start new research for our qTerm
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Fnac Darty Reports Share Buyback Transactions for June 2025
Fnac Darty's Own Share Transactions Overview Recently, the renowned retail group Fnac Darty disclosed its trading activities involving shares from June 23 to June 27, 2025. This announcement is part of its continued commitment to transparency in its financial operations and shareholder communications. Significance of Share Buybacks Buyback programs are strategic moves for...
Continue Reading
Reboot Studios Announces Innovative Jewish Media Projects for 2024
Reboot Studios Unveils Exciting Jewish Media Projects for 2024 A New Chapter in Jewish Storytelling Reboot Studios, which is dedicated to empowering creators and artists, has announced the projects that will be part of its 2024 Creator Fund lineup. This latest funding round builds on previous achievements, including the Oscar-shortlisted dark comedy The Anne Frank Gift...
Continue Reading
Sigrid Therapeutics Advances Diabetes Management with SiPore® Food
Innovative Access to SiPore® Technology Sigrid Therapeutics is thrilled to share that it has successfully secured U.S. market access for its groundbreaking SiPore® technology following the impressive results from the SHINE study, which is recognized as the largest study of its kind in prediabetes. About the SHINE Study The SHINE study provided pivotal insights into the...
Continue Reading
Strategic Investment by Cordatus Capital in Red Dot Buildings
Cordatus Capital's Strategic Move to Partner with Red Dot Buildings Cordatus Capital is thrilled to announce a significant majority investment in Red Dot Buildings, a pioneering manufacturer of complex metal building systems. This partnership marks a premier opportunity for both Cordatus and Red Dot to leverage their strengths and drive substantial growth. Red Dot is...
Continue Reading
Class Action Alerts: Opportunities for LULU, F, XPEL, and EXTR Investors
Understanding Recent Class Action Lawsuits for Major Companies Investors often find themselves unsure about how corporate decisions might affect their finances. Recently, a number of well-known companies have been caught up in class action lawsuits, which can have serious implications for shareholders. It's important for investors to grasp their legal position and explore...
Continue Reading